Question raised in Lok Sabha on Drug Resistant TB Cases, 06/12/2019. India has the largest number of individuals suffering from drug resistant TB. However, as per the latest global TB report, India ranks
<p>The key objective of this research was to generate new evidence on outpatient antibiotic prescription rate and patterns in the private sector in India. We used 12-month period (May 2013 to April 2014)
<p>The bi-directional relationship between poverty and tuberculosis (TB) is well established. Poverty aggravates material disadvantage, social exclusion, discrimination in participation across a wide range
These rules aim to make available a database of clinical establishments which are authorised to function and thereby improve public health quality by eliminating quacks The Union Ministry of public
According to the World Health Organisation (WHO), Colistin is a “reserve” antibiotic, which means it is supposed to be considered a “last-resort” option in treatment and used only in the most severe circumstances,
Antimicrobial resistance (AMR) – in which a microorganism (such as a bacterium, virus, fungus or parasite) becomes resistant to an antimicrobial drug used to treat infections caused by it – is possibly
In light of established principles and strategies for appropriate use of antimicrobial medicines, this paper examines studies on antimicrobial use trends across several countries in the Asia and Pacific
MUMBAI: Pharma major Gilead Sciences has failed to deliver on promises to make an important drug available to patients suffering from a life-threatening HIV-related infection in certain developing countries
The Bureau of Pharma PSUs of India (BPPI), which implements the Centre’s flagship affordable medicine scheme PMBJP, has found 25 batches of drugs of 18 pharmaceutical companies to be of substandard quality
<p>There is evidence that pathogenic bacteria can adapt to antiseptics upon repeated exposure. More alarming is the concomitant increase in antibiotic resistance that has been described for some pathogens.
